Featured ArticlesThe Latest

Insights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study

By January 28, 2025February 6th, 2025No Comments
Journal of Drugs in Dermatology JDD Article About Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series.

Featured Article

Who is at risk for hypertrophic scars and keloids? A study of 6,249 patients reveals that hypertrophic scars and keloids are significantly more common in Black/African American individuals (OR=1.74, P<0.01) and associated with conditions like scarring alopecia , rosacea, atopic dermatitis, and acne. These findings suggest a potential link to melanocyte activity and shared inflammatory pathways, highlighting IL-4 and IL-13 as therapeutic targets. Discover how these insights could shape future treatments.